FETZIMA is FDA approved for the treatment of Major Depressive Disorder (MDD) in adults.* If you're suffering from depression, find out if FETZIMA can help.
*FETZIMA is not approved for the management of fibromyalgia, and its efficacy and safety have not been established for that use.
FETZIMA is a prescription medicine proven effective for the treatment of depression in adults. Learn more about FETZIMA.
Talk to your doctor to learn if FETZIMA could be an option for you. The Doctor Discussion Guide can help.
Pay as little as $10 (save up to $145) for each of your next 12 prescriptions. Restrictions apply.
FETZIMA is FDA approved for the
treatment of Major Depressive
Disorder (MDD) in adults.* If
you're suffering from
depression,
find out if FETZIMA can help.
FETZIMA is not approved for the
management of fibromyalgia, and its
efficacy and safety have not been
established
for that use.
FETZIMA is a prescription medicine proven effective for the treatment of depression in adults. Learn more about FETZIMA.
Talk to your doctor to learn if FETZIMA could be an option for you. The Doctor Discussion Guide can help.
Pay as little as $10 (save up to $145) for each of your next 12 prescriptions. Restrictions apply.
FETZIMA® (levomilnacipran) extended-release capsules are a prescription medicine used to treat a certain type of depression called Major Depressive Disorder (MDD) in adults.
It is not known if FETZIMA is safe and effective for use in children.
FETZIMA is not for use for the management of fibromyalgia, and its efficacy and safety have not been established for that use.
FETZIMA may cause serious side effects, including:
Increased risk of suicidal thoughts or actions in some children, adolescents, and young adults. FETZIMA and other antidepressant medicines may increase suicidal thoughts or actions in some children and young adults, especially within the first few months of treatment or when the dose is changed. FETZIMA is not for use in children.
FETZIMA may cause serious side effects, including:
DO NOT take FETZIMA if you:
Do not start taking an MAOI for at least 7 days after you stop treatment with FETZIMA.
Before taking FETZIMA, tell your healthcare provider if you:
FETZIMA and other medicines may affect each other causing possible serious side effects.
FETZIMA may affect the way other medicines work and other medicines may affect the way FETZIMA works.
Do not start or stop any other medicines during treatment with FETZIMA without talking to your healthcare provider first. Stopping FETZIMA suddenly may cause you to have serious side effects.
Avoid drinking alcohol during treatment with FETZIMA. Do not drive, operate heavy machinery, or do other dangerous activities until you know how FETZIMA affects you. FETZIMA can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. The most common side effects of FETZIMA include:
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of FETZIMA. For more information, ask your healthcare provider or pharmacist.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
FETZIMA® (levomilnacipran) extended-release capsules are a prescription medicine used to treat a certain type of depression called Major Depressive Disorder (MDD) in adults.
It is not known if FETZIMA is safe and effective for use in children.
FETZIMA is not for use for the management of fibromyalgia, and its efficacy and safety have not been established for that use.
FETZIMA may cause serious side effects, including:
Increased risk of suicidal thoughts or actions in some children, adolescents, and young adults. FETZIMA and other antidepressant medicines may increase suicidal thoughts or actions in some children and young adults, especially within the first few months of treatment or when the dose is changed. FETZIMA is not for use in children.
FETZIMA may cause serious side effects, including:
DO NOT take FETZIMA if you:
Do not start taking an MAOI for at least 7 days after you stop treatment with FETZIMA.
Before taking FETZIMA, tell your healthcare provider if you:
FETZIMA and other medicines may affect each other causing possible serious side effects.
FETZIMA may affect the way other medicines work and other medicines may affect the way FETZIMA works.
Do not start or stop any other medicines during treatment with FETZIMA without talking to your healthcare provider first. Stopping FETZIMA suddenly may cause you to have serious side effects.
Avoid drinking alcohol during treatment with FETZIMA. Do not drive, operate heavy machinery, or do other dangerous activities until you know how FETZIMA affects you. FETZIMA can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. The most common side effects of FETZIMA include:
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of FETZIMA. For more information, ask your healthcare provider or pharmacist.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.